Get the Stockscreener App
5.47
6.17%
-0.36
Terns Pharmaceuticals Inc stock is traded at $5.47, with a volume of 1.27M.
It is down -6.17% in the last 24 hours and up +42.08% over the past month.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
See More
Previous Close:
$5.83
Open:
$5.69
24h Volume:
1.27M
Relative Volume:
1.43
Market Cap:
$477.73M
Revenue:
-
Net Income/Loss:
$-95.90M
P/E Ratio:
-4.1439
EPS:
-1.32
Net Cash Flow:
$-79.09M
1W Performance:
-9.59%
1M Performance:
+42.08%
6M Performance:
+22.65%
1Y Performance:
-29.60%
1-Day Range:
$5.42
$5.82
1-Week Range:
$5.42
$6.11
52-Week Range:
$1.865
$11.40
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Name
Terns Pharmaceuticals Inc
Sector
Industry
Phone
650-525-5535 EXT.101
Address
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Compare TERN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
5.47 | 509.18M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-28-25 | Initiated | William Blair | Mkt Perform |
| Oct-31-24 | Initiated | Oppenheimer | Outperform |
| Jun-22-23 | Initiated | Mizuho | Buy |
| Jun-07-23 | Initiated | Jefferies | Buy |
| May-31-23 | Initiated | ROTH MKM | Buy |
| May-08-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-14-23 | Initiated | JMP Securities | Mkt Outperform |
| Feb-07-23 | Initiated | UBS | Buy |
| Sep-12-22 | Initiated | H.C. Wainwright | Neutral |
| Sep-14-21 | Resumed | Goldman | Buy |
| Mar-02-21 | Initiated | Cowen | Outperform |
| Mar-02-21 | Initiated | Goldman | Buy |
| Mar-02-21 | Initiated | JP Morgan | Overweight |
View All
Terns Pharmaceuticals Inc Stock (TERN) Latest News
Terns Pharmaceuticals Inc. stock prediction for this weekLong Term Equity Screener with Safety Metrics - Newser
What makes Terns Pharmaceuticals Inc. stock price move sharplyNext Day Momentum Stock Forecasting Report - Newser
What catalysts could drive Terns Pharmaceuticals Inc. stock higher in 2025Wealth Building Planner With Proven Results - jammulinksnews.com
Terns Pharmaceuticals Inc. Earnings Report Breakdown: What Investors Should KnowEarly Breakout Tracker - beatles.ru
Best data tools to analyze Terns Pharmaceuticals Inc. stockFree Entry Plan for Oversold Reversal Stocks - Newser
Is Terns Pharmaceuticals Inc. stock overvalued or undervaluedReal Time Strategy For Consistent Profits - jammulinksnews.com
Multi asset correlation models including Terns Pharmaceuticals Inc.Weekly Stock Picks with Trend Confidence - Newser
Terns Pharmaceuticals Inc. stock trend forecastFree Risk Adjusted Technical Entry Plan - Newser
What institutional flow reveals about Terns Pharmaceuticals Inc.Short-Term Market Movement Forecast Report - Newser
Why Terns Pharmaceuticals Inc. stock attracts strong analyst attentionCommunity Picked Stocks with Trade Insights - Newser
Should I hold or sell Terns Pharmaceuticals Inc. stock in 2025Navigate the market with precision insights - jammulinksnews.com
What are Terns Pharmaceuticals Inc. company’s key revenue driversBuild wealth faster with consistent investment plans - jammulinksnews.com
What institutional investors are buying Terns Pharmaceuticals Inc. stockAmplify your gains with low-risk picks - jammulinksnews.com
How strong is Terns Pharmaceuticals Inc. company’s balance sheetCapitalize on emerging investment opportunities - jammulinksnews.com
What are the technical indicators suggesting about Terns Pharmaceuticals Inc.Powerful growth strategies - jammulinksnews.com
How volatile is Terns Pharmaceuticals Inc. stock compared to the marketAchieve rapid portfolio growth with expert guidance - jammulinksnews.com
What is the risk reward ratio of investing in Terns Pharmaceuticals Inc. stockBreakthrough profit margins - jammulinksnews.com
Published on: 2025-07-28 01:38:12 - jammulinksnews.com
What analysts say about Terns Pharmaceuticals Inc. stockMassive profits - Autocar Professional
What drives Terns Pharmaceuticals Inc. stock priceAccelerated earnings growth - PrintWeekIndia
Should I buy Terns Pharmaceuticals Inc. stock before earningsFree Investment Timing Strategies - jammulinksnews.com
Why Terns Pharmaceuticals Inc. stock is on top investor watchlistsRapid profit acceleration - jammulinksnews.com
Is Terns Pharmaceuticals Inc. a good long term investmentExceptional profit potential - PrintWeekIndia
What institutions are buying Terns Pharmaceuticals Inc. stock nowExceptional portfolio growth - jammulinksnews.com
Terns Pharmaceuticals Inc. Stock Analysis and ForecastUnmatched market gains - jammulinksnews.com
Terns Pharmaceuticals Inc Stock (TERN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):